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Background
The new anti allergic vaccine is based on purified aller-
gens from Dermatophagoides siboney and the combina-
tion adjuvant containing a TLR-4 ligand and alum. We
propose that IgG1/IgE ratio is effective to assess the
clinical efficacy of this experimental vaccine. Aim: To
evaluate the immunogenicity of formulation variants of
a D. siboney adjuvanted vaccine with varying levels of
allergen adsorption on to alum.
Methods
Vaccine formulations with different allergen adsorption
levels were obtained by variation of phosphate ions and
alum hydroxide content. In a preventative experimental
setting, BALB/c mice were treated subcutaneously with
3 doses of each vaccine variant seven days apart.
Further, mice were subjected to aerosol allergen chal-
lenge. The allergen-specific antibody response was
assessed by determining serum levels of IgE, IgG, IgG1
and IgG2a by ELISA, as well the local allergic response
by cytokine levels in broncho-alveolar lavage.
Results
All variants induced allergen-specific IgG1 and IgG2a
antibodies after three immunization doses. The low alum
variant showed significant reduction of IgE, whereas the
variant with the highest adsorption level (lowest phos-
phate content) showed significant increase of IgG1. In
contrast IgG2a antibodies were not affected by allergen
adsorption. A significant increase of the IgG1/IgE ratio
was observed for all variants in challenged mice as
compared to Th2 controls, with preponderance of the
variants with reduced alum content and highest adsorp-
tion level. Cytokine levels in BAL indicated a mild but
significant shift from Th2 to Th1/Th0 pattern. Histologi-
cal examination of lungs showed a diminished allergic
inflammatory response in vaccinated mice. Reduced size
of granulomes at injection site was noted in subjects vac-
cinated with the low alum formulation variant.
Conclusions
Serum IgG1/IgE ratio can be indicative of a protective
immunogenicity in a murine model of respiratory
allergy. Higher allergen adsorption on to alum could be
related to a more effective presentation pathway, or to
the function of IgG1 as blocking antibody.
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